Assembly Biosciences Inc
NASDAQ:ASMB 9:47:48 AM EDT
Market Cap (Intraday) | 141.15M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $17.47 |
50-Day MA | $14.33 |
200-Day MA | $14.38 |
Assembly Biosciences Inc Stock, NASDAQ:ASMB
Two Tower Place, 7th floor, South San Francisco, California 94080
United States of America
Phone: +1.833.509.4583
Number of Employees: 65
Description
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.